Henri Lajeunesse

Henri is a lawyer in Intellectual Property and Business Law, and a member of ROBIC’s Emerging Technologies Group and Life Sciences Group. His practice focuses primarily on commercial law and technology transfer. He assists and advises various companies, from start-ups to consortia, as well as non-profit organizations and multinationals, on business strategies and the drafting and negotiation of various commercial agreements. He also assists for the firm’s clients in transactions such as financings and mergers and acquisitions.

In addition to his two bachelor’s degrees in biology (B.Sc.) and law (LL.B.) from the Université Laval, Henri holds a master’s degree in pharmaceutical sciences (M.Sc.) from the University of Montréal with a specialization in drug development and regulatory affairs. With his academic background in both law and science, he has expertise in various industries, such as life sciences, pharmaceuticals, cannabis, software and emerging technologies.

Prior to joining ROBIC, Henri worked at a leading international law firm and collaborated with the legal department team of a global pharmaceutical company on a wide range of issues related to the protection and enforcement of intellectual property assets.